Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education courses for attorneys; certification courses for physicians; certification for industry workers; general education seminars; and on-site training, as well as consulting, digital publishing, marketing, and franchising related to medical cannabis through its Pharmacology University. It is also involved in clinical trials and medical research services through its Alpha Research Institute; and sale of CBD products. The company was founded in 2003 and is headquartered in Houston, Texas.
0 transactions — 0 buys and 0 sales reported by Cannabis Bioscience International Holdings, Inc. executives.
0 institutional funds report a position on CBIH in their latest SEC quarterly filing.
5 recent articles on CBIH.
Beyond raw data, we aggregate and score every smart money signal to give you a unique view.
8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.
Detection of clustered purchases or sales by several executives in the same stock.
Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.
NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.
Spot marked changes in search interest around the stocks being followed.
Create your watchlist and receive a brief of events affecting your tickers.
This public page only shows a preview. The full analysis of CBIH on the Kairos Insider dashboard includes:
Free signup · Pro €19/month or €190/year